Emerging therapies in immunoglobulin A nephropathy
نویسندگان
چکیده
منابع مشابه
Glomerular diseases: emerging tests and therapies for IgA nephropathy.
The last decade has seen major progress in understanding the pathogenesis as well as the prognosis and treatment of patients with IgA nephropathy (IgAN). Although the diagnostic criterion of a kidney biopsy demonstrating dominant or codominant IgA deposition remains unchanged, much more is known about the genetic and environmental factors predisposing to disease development and progression. The...
متن کاملManagement in immunoglobulin A nephropathy.
158 Hong Kong Med J Vol 15 No 2 # April 2009 # To the Editor— I read with interest the article by Cheung et al,1 who stated that there is still no effective treatment for immunoglobulin (Ig) A nephropathy. Some points need to be clarified however. Firstly, combination of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker is firstline therapy to preserve glomerular filtrati...
متن کاملEmerging Drug Therapies for Heart Failure
Heart failure is associated with high morbidity and mortality and is proving to be an economic burden in developing countries. A number of therapeutic agents are presently employed in heart failure; but they are not sufficient to control symptoms of heart failure. Moreover, the prevalence of chronic heart failure is progressively increasing and thus there is a continuing need to develop effecti...
متن کاملGenetics of immunoglobulin A nephropathy.
INTRODUCTION Immunoglobulin (Ig) A nephropathy is the most common primary glomerulonephritis in the world and about 20% to 50% of patients with it develop progressive renal failure. There is considerable evidence to show that IgA nephropathy is influenced by genetic factors. The purpose of this review is to provide useful information concerning genetics of IgA nephropathy. METHODS AND RESULTS...
متن کاملReport of a Case of Immunoglobulin A Nephropathy in a Patient Without a Family History of Kidney Disease
Introduction: IgA Nephropathy is the most common form of glomerulonephritis and the major cause of end-stage renal disease. Gross or microscopic hematuria is a common symptom of hematuria and occurs in less than 5% to 10% of patients with IGM with rapidly progressive glomerulonephritis. The aim of this study was to investigate the diagnostic biomarkers of this disease after biopsy. Methods: IgA...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nephrology
سال: 2015
ISSN: 1320-5358
DOI: 10.1111/nep.12527